Professor | 姜海 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	姜海
Language ability	英语, 中文
Province	北京

Upload Avatar (500 x 500)

Name

姜海

Language ability

英语, 中文

Province

北京

University/Lab Affiliation and Title	中国科学院大学
Faculty	Life Sciences

University/Lab Affiliation and Title

中国科学院大学

Faculty

Life Sciences

Areas of Focus	药物靶点筛选侵袭性淋巴瘤早期诊断化疗药物疗效预测基因功能与应用
Publications	DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines, 姜海, 2022 Defining relative mutational difficulty to understand cancer formation, Shan, Lin, Yu, Jiao, He, Zhengjin, Chen, Shishuang, Liu, Mingxian, Ding, Hongyu, Xu, Liang, Zhao, Jie, Yang, Ailing, Jiang, Hai, 2020 SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling, Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang, 2020 Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss, 丁红玉, 赵洁, 张艳丽, 于皎, 刘明贤, 李晓曦, 徐亮, 林明辉, 刘川, 何正金, 陈奭爽, 姜海, 2019 UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma, 李晓曦, 张艳丽, 郑丽婷, 刘明贤, 陈德桂, 姜海, 2018 A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk, 王宁, 丁红玉, 刘川, 李晓曦, 魏丽, 于皎, 刘明贤, 应明, 高伟, 姜海, 王亚杰, 2015 A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency, 刘川, 丁红玉, 李晓曦, Pallasch, Christian P, 洪丽雅, 郭殿武, 陈奭爽, 王迪飞, 王伟, 王亚杰, Hemann, Michael T, 姜海, 2015

Areas of Focus

药物靶点筛选
侵袭性淋巴瘤早期诊断
化疗药物疗效预测
基因功能与应用

Publications

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines, 姜海, 2022
Defining relative mutational difficulty to understand cancer formation, Shan, Lin, Yu, Jiao, He, Zhengjin, Chen, Shishuang, Liu, Mingxian, Ding, Hongyu, Xu, Liang, Zhao, Jie, Yang, Ailing, Jiang, Hai, 2020
SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signaling, Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang, 2020
Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss, 丁红玉, 赵洁, 张艳丽, 于皎, 刘明贤, 李晓曦, 徐亮, 林明辉, 刘川, 何正金, 陈奭爽, 姜海, 2019
UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma, 李晓曦, 张艳丽, 郑丽婷, 刘明贤, 陈德桂, 姜海, 2018
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk, 王宁, 丁红玉, 刘川, 李晓曦, 魏丽, 于皎, 刘明贤, 应明, 高伟, 姜海, 王亚杰, 2015
A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency, 刘川, 丁红玉, 李晓曦, Pallasch, Christian P, 洪丽雅, 郭殿武, 陈奭爽, 王迪飞, 王伟, 王亚杰, Hemann, Michael T, 姜海, 2015

药物靶点筛选系统侵袭性淋巴瘤早期诊断化疗疗效预测基因功能应用小鼠模型肿瘤抑制因子

杨桦 - 同济大学

陈明洁 - 华中科技大学

袁玲 - 中南大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们